European Medicines Agency – AZ vaccine is safe and should be used. Cannot disprove link to very rare blood clotting events. Says this rare risk should be noted in documentation. Scientific position is “this is a safe and effective option to protect against Covid 19”
— seanwhelanRTE (@seanwhelanRTE) March 18, 2021
UK reports five cases of ‘rare’ blood clot after AstraZeneca jab https://t.co/YW9RzbsXvF
— breakingnews.ie (@breakingnewsie) March 18, 2021
Dr Colm Henry, Chief Clinical Officer, HSE at Dr Steevens’ Hospital for the weekly HSE operational update on the response to Covid-19
Weekly HSE briefing at Dr Steevens’ Hospital, Dublin.
Ahead of a decision expected this evening from the European Medicines Agency (EMA) whether or not the AstraZeneca Covid-19 vaccine is safe to continue to use after incidents of blood clotting.
“We have had a number of clotting events, in which there has been no link in terms of cause and effect of those vaccinations. They may well have been coincidental but they’re under investigation.
“In any population based screening program other things will happen that will happen anyhow in unvaccinated people – illness, hospitalisation, even death.
“There have been a number of cases of clotting and none of the unusual type, and it’s to be expected with this heightened sense of awareness that there will be improved reporting on those to HPRA (Health Products Regulatory Authority].
It will investigate these and inform us if there’s any is any cause for concern, and none has been expressed to date.”
Dr Colm Henry, Chief Clinical Officer, HSE